M&A Deal Summary

WebMD Health Acquires StayWell

On March 12, 2020, WebMD Health acquired publishing company StayWell from Merck

Acquisition Highlights
  • This is WebMD Health’s 1st transaction in the Publishing sector.
  • This is WebMD Health’s 13th transaction in the United States.
  • This is WebMD Health’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2020-03-12
Target StayWell
Sector Publishing
Buyer(s) WebMD Health
Sellers(s) Merck
Deal Type Divestiture

Target

StayWell

Yardley, Pennsylvania, United States
website
Staywell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. Staywell was founded in 1978 and is headquartered in St. Paul, Minnesota.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

WebMD Health

New York, New York, United States

website


Category Company
Sector Digital Media
Employees1,700
Revenue 705M USD (2016)
DESCRIPTION

WebMD Health Corp. is a provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications. WebMD Health Corp. is based in New York City.


DEAL STATS #
Overall 15 of 25
Sector (Publishing) 1 of 1
Type (Divestiture) 1 of 1
State (Pennsylvania) 1 of 2
Country (United States) 13 of 20
Year (2020) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-30 Aptus Health

Reading, Massachusetts, United States

Aptus Health offers health and life sciences companies a truly connected approach to engaging healthcare professionals, consumers and other stakeholders through an array of high-value digital information channels and services. By applying this portfolio of assets—informed by rich engagement data and analytics—Aptus designs and builds integrated multichannel engagement solutions that allow its clients to dynamically connect with their customers at key points in their decision-making journeys and impact behavior at scale.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-27 coliquio

Konstanz, Germany

coliquio GmbH is an information and education platform for healthcare professionals. coliquio was established in 2007 and is based in Konstanz, Germany.

Buy -

Seller(S) 1

SELLER

Merck

Rahway, New Jersey, United States

website


Category Company
Founded 1891
Sector Life Science
Employees67,000
Revenue 59.3B USD (2022)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.


DEAL STATS #
Overall 6 of 7
Sector (Publishing) 1 of 1
Type (Divestiture) 6 of 6
State (Pennsylvania) 2 of 2
Country (United States) 6 of 7
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-09 ArQule

Burlington, Massachusetts, United States

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. ArQule's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule was formed in 1993 and is based in Burlington, Massachusetts.

Buy $2.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-13 Virbac SA - SENTINEL U.S. Rights

New Jersey, United States

Virbac SA - SENTINEL U.S. Rights comprises two canine products Sentinel Flavor Tabs and Sentinel Spectrum which provides protection against 5 different kinds of parasites.

Buy $400M